EBS Equity Snapshot

MOLN Weekly Equity Report

Molecular Partners AG

Interactive chart JSON snapshot
Latest Close 3.03 CHF 12 Jun 2026
1W Return 1.0% latest completed week
4W Return 2.0% short-term follow-through
12W Return -16.1% quarterly tape
Trend Breadth 36.5% 19 of 52 weeks active
Volume Ratio 0.3x vs 13-week average
Company Brief

What the company does

Molecular Partners AG, a clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland. Its product pipeline comprises MP0317, which is in Phase 2 clinical trial for the treatment of advanced solid tumors; MP053, novel tetra-specific T cell-engaging DARPin, which is phase 1 clinical trial for the treatment of acute myeloid leukemia; and MP0712, a 212Pb Radio-DARPin therapy (RDT) candidate targeting the tumor-associated protein delta-like ligand 3 (DLL3) which is in Phase 1 clinical trial to treat SCLC and neuroendocrine tumors. It also researches for Switch-DARPin …

Snapshot

What the weekly tape is saying

MOLN closed the latest completed week at 3.03 CHF. The 4-week return is 2.0% and the 12-week return is -16.1%. Trend Signal is inactive, Market Dynamics is -1.15. Setup signature: Risk-first tape with a 24/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -9.0%
Volume 0.3x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 20 Persistence of active Trend Signal over the last year and current streak.
Momentum 40 Blend of 4-week and 12-week follow-through.
Dynamics 26 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 16 Relative leadership and short-term RS change.
Volume 14 Participation compared with the 13-week volume baseline.
Risk Control 28 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
3.33 CHF
Vs Trend Line
-9.0%
Fair Value
3.96 CHF
Vs Fair Value
-23.6%
52W High
3.96 CHF
52W Low
2.66 CHF
Drawdown
-23.5%
Range Position
28.5%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 1.0%
4W 2.0%
12W -16.1%
26W -10.4%
52W -2.7%

Trend read

Active Streak
0 weeks
52W Active Weeks
19
52W Active Breadth
36.5%
Sector Scope
CH Healthcare
Sector Rank
16 of 41
Sector Percentile
62.5%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-1.15
4W MD Change
-46.9%
Relative Strength
-11.06
4W RS Change
-5.7%
Expectation
Negative
Probability
38.51%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
44.4K
13W Average
131.4K
52W Average
121.0K
Vs 13W
0.3x
Vs 52W
0.4x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
5.0%
52W Volatility
5.3%
Upside Weeks
23
Downside Weeks
26
Downside Breadth
50.0%
Avg Gain / Loss
4.8% / -4.1%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
EBS
Country
CH
Sector
Healthcare
Industry
Biotechnology
Currency
CHF
Market Cap
117.8M

Opportunity signals

  • No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Market Dynamics is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 3.03 CHF 1.0% 3.33 CHF 3.96 CHF -1.15 -11.06 44.4K Off
5 Jun 2026 3.00 CHF -4.5% 3.34 CHF 3.98 CHF -1.09 -10.08 66.1K Off
29 May 2026 3.14 CHF -0.3% 3.35 CHF 4.00 CHF -0.96 -7.08 61.1K Off
22 May 2026 3.15 CHF 6.1% 3.34 CHF 4.02 CHF -0.90 -6.73 171.4K Off
15 May 2026 2.97 CHF -8.0% 3.33 CHF 4.04 CHF -0.78 -10.46 152.3K Off
8 May 2026 3.23 CHF 0.6% 3.33 CHF 4.06 CHF -0.69 -2.04 107.3K Off
1 May 2026 3.21 CHF -1.8% 3.32 CHF 4.08 CHF -0.61 -3.19 35.9K Off
24 Apr 2026 3.27 CHF 0.0% 3.31 CHF 4.09 CHF -0.55 -1.84 275.4K Off
17 Apr 2026 3.27 CHF -3.3% 3.29 CHF 4.11 CHF -0.61 -4.00 76.1K On
10 Apr 2026 3.38 CHF 4.8% 3.28 CHF 4.13 CHF -0.26 0.85 111.4K On
3 Apr 2026 3.23 CHF -0.6% 3.26 CHF 4.14 CHF -0.18 -2.51 129.8K On
27 Mar 2026 3.25 CHF -10.1% 3.25 CHF 4.16 CHF 0.27 1.12 131.1K On
20 Mar 2026 3.61 CHF 7.9% 3.24 CHF 4.17 CHF 0.65 14.49 345.7K On
13 Mar 2026 3.35 CHF -14.2% 3.22 CHF 4.18 CHF 0.60 2.00 122.0K On